Feedback / Questions
lucicebtide (ST101) - Sapience Therap
https://www.prnewswire.com/news-releases/sapience-therapeutics-provides-data-update-from-phase-2-trial-of-lucicebtide-in-patients-with-glioblastoma-at-the-2025-american-society-of-clinical-oncology-asco-annual-meeting-302470177.html
Jun 2, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next